Clinical Read2026-06-02

KEYTRUDA (pembrolizumab) + plinabulin / docetaxel - (KeyPelms-004 / 303 Study) (TROPION Lung-01)

BeyondSpring Inc.BYSI
Indication
2L/3L Non-small cell lung cancer (NSCLC)
Stage
phase2
Event
Phase 2